InsidersTradesSigma
Track the Healius Limited stock price and the full insider trade history of the company, a listed issuer based in Australia. Shares are listed on the AU market, under the supervision of ASX. Operating in the Health Care sector, Healius Limited has recorded 14 insider filings. Market capitalisation: €315.9m. The latest transaction was disclosed on 28 August 2026 (Change in Substantial Holding). Among the most active insiders: its controlled bodies corporate listed in Annexure A. Every trade is accessible without an account.
14
Insider Decl.
n/a
Thresholds
€12,203
3 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Healius Limited Hold (neutral), based on 10 analysts. Average price target: A$0.55.
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,303 of 29,062 companies
43.9
score / 100
Value52
Quality36
FCF yld72%
Earn yld-49%
EV/EBITDA·
ROE-108%
Gross mgn84%
Net mgn-11%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 28 August 2026
Declarations14 total
ShareASXISIN AU0000033359ASX:2924-03128456-2A1693338
ShareASXISIN AU0000033359ASX:2924-03108338-2A1682964
ShareASXISIN AU0000033359ASX:2924-03099875-2A1677246
ShareASXISIN AU0000033359ASX:2924-03095343-2A1674626
ShareASXISIN AU0000033359ASX:2924-03093884-2A1673899
22,978 shares@ A$0.87040.0059% mcap100.0% of flowShareASXISIN AU0000033359ASX:2924-03081721-2A1667897
14 of 14 declarations
关于 Healius Limited
Healius Limited 是一家澳大利亚公司，专门从事健康和诊断服务。它主要在澳大利亚证券交易所 (XASX) 运营。
